Naumann, N.; LĂĽbke, J.; Baumann, S.; Schwaab, J.; Hoffmann, O.; Kreil, S.; Dangelo, V.; Reiter, L.; Bugert, P.; Kristensen, T.;
et al. Adverse Prognostic Impact of the KIT D816V Transcriptional Activity in Advanced Systemic Mastocytosis. Int. J. Mol. Sci. 2021, 22, 2562.
https://doi.org/10.3390/ijms22052562
AMA Style
Naumann N, LĂĽbke J, Baumann S, Schwaab J, Hoffmann O, Kreil S, Dangelo V, Reiter L, Bugert P, Kristensen T,
et al. Adverse Prognostic Impact of the KIT D816V Transcriptional Activity in Advanced Systemic Mastocytosis. International Journal of Molecular Sciences. 2021; 22(5):2562.
https://doi.org/10.3390/ijms22052562
Chicago/Turabian Style
Naumann, Nicole, Johannes LĂĽbke, Sofie Baumann, Juliana Schwaab, Oliver Hoffmann, Sebastian Kreil, Vito Dangelo, Lukas Reiter, Peter Bugert, Thomas Kristensen,
and et al. 2021. "Adverse Prognostic Impact of the KIT D816V Transcriptional Activity in Advanced Systemic Mastocytosis" International Journal of Molecular Sciences 22, no. 5: 2562.
https://doi.org/10.3390/ijms22052562
APA Style
Naumann, N., LĂĽbke, J., Baumann, S., Schwaab, J., Hoffmann, O., Kreil, S., Dangelo, V., Reiter, L., Bugert, P., Kristensen, T., Sotlar, K., Haselmann, V., Schneider, S., Metzgeroth, G., Weiss, C., Popp, H. D., Fabarius, A., Hofmann, W.-K., Cross, N. C. P.,
... Jawhar, M.
(2021). Adverse Prognostic Impact of the KIT D816V Transcriptional Activity in Advanced Systemic Mastocytosis. International Journal of Molecular Sciences, 22(5), 2562.
https://doi.org/10.3390/ijms22052562